Tics and Tourette's syndrome in childhood

Seminars in Pediatric Neurology

Volumn 10, Issue 1, 2003, Pages 35-40

  Kuperman, Samuel ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; BENZATROPINE; CENTRAL STIMULANT AGENT; CLONIDINE; DIPHENHYDRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; GUANFACINE; HALOPERIDOL; PIMOZIDE; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT; ZIPRASIDONE;

AKATHISIA; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; CONSTIPATION; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; DYSTONIA; FACE DISORDER; GAIT DISORDER; GILLES DE LA TOURETTE SYNDROME; GYNECOMASTIA; HEADACHE; HUMAN; HYPERSALIVATION; LACTATION; LOW DRUG DOSE; MENTAL DISEASE; MOTOR DYSFUNCTION; MUSCLE STIFFNESS; NEUROLEPTIC MALIGNANT SYNDROME; NEUROPATHOLOGY; OPISTHOTONUS; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PATHOPHYSIOLOGY; QT INTERVAL; REVIEW; SEDATION; SIDE EFFECT; SOUND; TARDIVE DYSKINESIA; TIC; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN; XEROSTOMIA;

EID: 0038662660     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9091(02)00007-4     Document Type: Review

References (47)

1. Fish DR, Sawyers D, Allen PJ, et al: The effect of sleep on the dyskinetic movements of Parkinson's disease, Gilles de la Tourette syndrome, Huntington's disease, and torsion dystonia. Arch Neurol 48:210-214, 1991
2. Leckman JF, Pauls DL, Peterson BS, et al: Pathogenesis of Tourette syndrome, in Chase T, Friedhoff AJ, Cohen DJ (eds): Advances in Neurology: Tourette's Syndrome. New York, Raven Press, 1992, pp 15-24
3. Shapiro E, Shapiro AK: Semiology, nosology and criteria for tic disorders. Rev Neurol 142:824-832, 1986
4. Kurlan R: Hypothesis II: Tourette's syndrome is part of a clinical spectrum that includes normal brain development. Arch Neurol 51:1145-1150, 1994
5. Shapiro AK, Shapiro ES, Bruun RD, et al: Gilles de la Tourette Syndrome. New York, Raven Press, 1978
6. Bruun RD, Budman CL: The course and prognosis of Tourette syndrome. Neurol Clin 15:291-298, 1997
7. Kurlan R, Behr J, Medved L, et al: Severity of Tourette's syndrome in one large kindred: Implication for determination of disease prevalence rate. Arch Neurol 44:268-269, 1987
8. Leckman JF, Peterson BS, Pauls DL, et al: Tic disorders. Psychiatr Clin N Am 20:839-861, 1997
9. Shapiro AK, Shapiro ES, Young JG, et al: Gilles de la Tourette Syndrome (2nd ed). New York, Raven Press, 1988
10. Jagger J, Prusoff BA, Cohen DJ, et al: The epidemiology of Tourette's syndrome: A pilot study. Schizophr Bull 8:267-278, 1982
11. Bruun RD, Budman CL: The natural history of Tourette syndrome. Adv Neurol 58:1-6, 1992
12. Jankovic J, Rohaidy H: Motor, behavioral and pharmacologic findings in Tourette's syndrome. Can J Neurol Sci 14:541-546, 1987
13. Goldenberg JN, Brown SB, Weiner WJ: Coprolalia in younger patients with Gilles de la Tourette syndrome. Mov Disord 9:622-625, 1994
14. Leckman JF, Zhang H, Vitale A, et al: Course of tic severity in Tourette syndrome: The first two decades. Pediatrics 102:14-19, 1998
15. Goetz CG, Tanner CM, Stebbins GT, et al: Adult tics in Gilles de la Tourette's syndrome: Description and risk factors. Neurology 42:784-788, 1992
16. Lucas AR, Beard CM, Rajput AH, et al: Tourette syndrome in Rochester, Minnesota, 1968-1979, in Chase TN, Friedhoff AJ (eds): Advances in Neurology: Gilles de la Tourette Syndrome. New York, Raven Press, 1982, pp 267-269
17. Robertson MM, Verrill M, Mercer M, et al: Tourette's syndrome in New Zealand: A postal survey. Br J Psychiatry 164:263-266, 1994
18. Comings DE, Comings BG: A controlled study of Tourette syndrome, I: Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 41:701-741, 1987
19. Leckman JF, Walker DE, Goodman WK, et al: "Just right" perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry 151:675-680, 1994
20. Robertson MM, Trimble MR, Lees AJ: The psychopathology of the Gilles de la Tourette syndrome: A phenomenological analysis. Br J Psychiatry 152:383-390, 1988
21. Holzer JC, Goodman WK, McDougle CJ, et al: Obsessive-compulsive disorder with and without a chronic tic disorder: A comparison of symptoms in 70 patients. Br J Psychiatry 164:469-473, 1994
22. Leckman JF, Grice DE, Barr LC, et al: Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety 1:208-215, 1994
23. Price RA, Kidd KK, Cohen DJ, et al: A twin study of Tourette syndrome. Arch Gen Psychiatry 42:815-820, 1985
24. Curtis D, Robertson MM, Gurling HM: Autosomal dominant gene transmission in a large kindred with Gilles de la Tourette syndrome. Br J Psychiatry 160:845-849, 1992
25. Kidd KK, Pauls DL: Genetic hypotheses for Tourette syndrome, in Friedhoff AJ, Chase TN (eds): Advances in Neurology: Gilles de la Tourette Syndrome. New York, Raven Press, 1982, 243-249
26. Singer HS: Neurobiology of Tourette syndrome. Neurol Clin 15:357-379, 1997
27. Peterson BS, Leckman JF, Duncan JS, et al: Corpus callosum morphology from magnetic resonance images in Tourette's syndrome. Psychiatry Res 55:85-99, 1994
28. Singer HS, Reiss AL, Brown JE, et al: Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 43:950-956, 1993
29. Baumgardner TL, Singer HS, Denckla MB, et al: Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology 47:477-482, 1996
30. George MS, Trimble MR, Costa DC, et al: Elevated frontal cerebral blood flow in Gilles de la Tourette syndrome: A 99Tcm-HMPAO SPECT study. Psychiatry Res 45:143-151, 1992
31. Hall M, Costa DC, Shields J, et al: Brain perfusion patterns with 99Tcm-HMPAO/SPECT in patients with Gilles de la Tourette syndrome-short report, in Schmidt HAB, vander Schoot JB (eds): Nuclear Medicine: The State of the Art of Nuclear Medicine in Europe. Stuttgart, Schattauer, 1991, pp 243-245
32. Braun AR, Stoetter B, Randolph C, et al: The functional neuroanatomy of Tourette's syndrome: An FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 9:277-291, 1993
33. Malison RT, McDougle CJ, van Dyck CH, et al: [123I]β-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry 152:1359-1361, 1995
34. Swedo SE, Leonard HL, Garvey M, et al: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155:264-271, 1998
35. Perlmutter SJ, Leitman SF, Garvey MA, et al: Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354:1153-1158, 1999
36. Chappell PB, Leckman JF, Riddle MA: The pharmacologic treatment of tic disorders. Child Adolesc Psychiatr Clin N Am 4:197-216, 1995
37. Scahill L, Chappell PB, Kim YS, et al: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067-1074, 2001
38. Regeur L: Clinical evaluation and pharmacological treatment of Gilles de la Tourette's syndrome and other hyperkinesias. Acta Neurol Scand Suppl 137:48-50, 1992
39. Shapiro AK, Shapiro E, Eisenkraft GJ: Treatment of Gilles de la Tourette syndrome with pimozide. Am J Psychiatry 140:1183-1186, 1983
40. Shapiro E, Shapiro AK, Fulop G, et al: Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 46:722-730, 1989
41. Fulop G, Phillips RA, Shapiro AK, et al: ECG changes during haloperidol and pimozide treatment of Tourette's disorder. Am J Psychiatry 144:673-675, 1987
42. Bruggeman R, van der LC, Buitelaar JK, et al: Risperidone versus pimozide in Tourette's disorder: A comparative double-blind parallel-group study. J Clin Psychiatry 62:50-56, 2001
43. Sallee FR, Kurlan R, Goetz CG, et al: Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study. J Am Acad Child Adolesc Psychiatry 39:292-299, 2000
44. McDougle CJ, Goodman WK, Leckman JF, et al: Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 51:302-308, 1994
45. Gadow KD, Sverd J, Sprafkin J, et al: Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry 56:330-336, 1999
46. Pliszka SR, Greenhill LL, Crismon ML, et al: The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. J Am Acad Child Adolesc Psychiatry 39:920-927, 2000
47. Pliszka SR, Greenhill LL, Crismon ML, et al: The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 39:908-919, 2000